Novo Nordisk A/S: Company Profile and SWOT AnalysisiCD ResearchFebruary 4, 2012 48 Pages - SKU: ICDR6793719 |
| Synopsis ICD Research's Novo Nordisk A/S .: Company Profile and SWOT Analysis contains in depth information and data about the company and its operations. The profile contains a company overview, business description, competitive benchmarking, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company. Summary ICD Research's Novo Nordisk A/S .: Company Profile and SWOT Analysis is a crucial resource for industry executives and anyone looking to access key information about Novo Nordisk A/S. ICD Research's Novo Nordisk A/S .: Company Profile and SWOT Analysis report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
Novo Nordisk A/S (Novo Nordisk) is a leading provider of diabetic care products across the world. The company also maintains leading positions within growth hormone therapy, haemophilia care, and hormone replacement therapy. Novo Nordisk discovers, develops, manufactures, and markets pharmaceutical products and services for patients, medical professionals and society. The company classifies its operations under two segments - Diabetes care and Biopharmaceuticals. It has a network of subsidiaries, affiliates, and offices in 74 countries, and markets its products in over 180 countries across the world. Novo Nordisk is headquartered in Bagsvaerd, Denmark. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

